Delivery Order SPE2DB22D3004-SPE2DB24FPJ03
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $9,550.17 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This contract is for the supply of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $13,866.16 contract is for the supply of the prescription drug RINVOQ ER 15 MG TABLET. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. The contract has a completion date of February 7, 2024 and was awarded on February 6, 2024....
- The Defense Logistics Agency (DLA) awarded a $6,360.11 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply RINVOQ ER 30 MG TABLET. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a potential value of $4,685.46 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a completion date of February 22, 2024 and a potential value of $12,030.84. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract was issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,983.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564110483 RINVOQ ER 30 MG TABLET UU 30S. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,040.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor to provide a comprehensive range of pharmaceutical products and...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPJ03Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. The contract is for the supply of RINVOQ ER 15 MG TABLET with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, most notably the Department of Defense. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 2/15/24 |